Vitrectomy devices market seen reaching $2.65 billion by 2030

The Business Research Company says the global vitrectomy devices market will grow from $1.89 billion in 2026 to $2.65 billion by 2030, driven by diabetes, retinal disease treatment and broader use of minimally invasive eye surgery. North America led the market in 2025, while Asia-Pacific is projected to grow fastest.

Why it matters: - Vitrectomy devices are used in eye surgeries that remove vitreous gel to treat serious retinal conditions. - Demand for these tools is rising as more patients need retinal care, especially those with diabetes-related eye disease. - The market outlook signals more spending on ophthalmic surgery equipment, eye care infrastructure and newer surgical platforms.

What happened: - The Business Research Company released a report on the vitrectomy devices market covering size, trends and a global forecast from 2026 to 2035. - The market is projected to rise from $1.74 billion in 2025 to $1.89 billion in 2026. - The report forecasts the market will reach $2.65 billion by 2030. - The report links growth to advances in ophthalmic surgery, rising eye health concerns and demographic shifts.

The details: - Vitrectomy devices are specialized surgical instruments used to remove the vitreous gel inside the eye. - The devices are used in procedures for retinal detachment, vitreous hemorrhage and other complex retinal diseases. - The market grew in recent years on higher rates of retinal disorders, more ophthalmic surgeries, an aging population, better access to eye care and adoption of advanced surgical equipment. - The market is expected to grow at an 8.4% CAGR from 2025 to 2026. - The forecast to 2030 implies an 8.9% CAGR. - Growth drivers include more outpatient ophthalmic surgeries, more investment in eye care infrastructure, broader access to advanced retinal treatments and a stronger focus on surgical safety and efficiency. - Emerging trends include wider use of minimally invasive vitrectomy systems, small-gauge instruments, improved illumination technologies, single-use surgical kits and next-generation vitrectomy platforms. - The report says expanded capabilities in its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

Between the lines: - Diabetes is a major demand driver because advanced diabetic retinopathy can require vitrectomy surgery when bleeding or scar tissue affects vision. - The report uses diabetes prevalence as a proxy for future procedure volume and device demand. - In June 2024, the UK National Health Service reported 3,615,330 people were registered with non-diabetic hyperglycemia in 2023, up from 3,065,825 in 2022. - That was nearly an 18% increase, pointing to a larger future patient base for retinal treatment. - North America held the largest market share in 2025, reflecting established healthcare infrastructure and strong demand for advanced ophthalmic surgery. - Asia-Pacific is expected to post the fastest growth, helped by higher healthcare investment, expanding eye care services and more retinal disease cases. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

What's next: - The market is expected to keep expanding through 2030 as more procedures move outpatient and more hospitals adopt newer retinal surgery tools. - The report points to next-generation vitrectomy platforms and single-use kits as likely areas of product development and competition. - Broader regional growth will likely depend on access to eye care, surgical capacity and investment in ophthalmology services.

The bottom line: - Vitrectomy devices are moving from a niche surgical category toward a steady growth market, with diabetes, retinal disease and technology upgrades driving demand.